Sector News

DSM acquires animal health, nutrition businesses from Erber Group for more than $1 billion

June 16, 2020
Chemical Value Chain

DSM has reached an agreement to acquire the Biomin and Romer Labs businesses from Erber Group (Getzersdorf, Austria), an animal nutrition and health company, for an enterprise value of €980 million ($1.1 billion).

Erber Group’s Sanphar and EFB businesses, representing 7% of its total sales, are not included in this transaction and will “be carved out before closing,” DSM says. The deal is subject to customary conditions and expected to close in the fourth quarter of 2020.

The value of the transaction represents an EV/EBITDA multiple of about 14 times 2020 EBITDA, the company says. The acquisition will be debt financed, with committed bridge financing in place. DSM says it continues to benefit from a strong balance sheet and remains committed to maintaining a strong investment-grade credit profile.

The acquired businesses, Biomin and Romer Labs, specialize primarily in mycotoxin risk management, gut health performance management, and food and feed safety diagnostic solutions. They have combined annual sales of €330 million and an adjusted EBITDA margin above 20% for the 12 months ended March 2020, with a high single-digit organic sales growth rate over the past five years, DSM says.

DSM expects the acquisition to provide revenue-enhancing synergies. The earnings per share contribution of the acquisition in 2021 is expected to be €0.15, DSM says. “Biomin and Romer Labs will help strengthen and accelerate the growth of our specialty animal nutrition and health offering, including our big data and diagnostic capabilities, and it is exciting to be entrusted to take these family-founded businesses forward,” say Geraldine Matchett and Dimitri de Vreeze, co-CEOs at DSM.

Erich Erber, founder and president of Erber Group, says that under DSM, “Biomin and Romer Labs will be able to use their new scale to intensify our joint contribution to a more sustainable world’s food supply.”

DSM says that Biomin’s technology provides protection against mycotoxins that occur as a result of natural fungus contaminants in animal feed and threaten the health of animals and humans. It is also a producer of phytogenic and probiotic feed alternatives to antibiotics. Romer Labs offers diagnostic technology with testing solutions for the analysis of mycotoxins in feed and food, food allergens and pathogens, as well as veterinary drug residues, with accredited full-service labs in Austria, the UK, the US, and Singapore, DSM says.

By: Sotirios Frantzanas

Source: Chemical Week

Related News

March 6, 2021

New catalyst makes styrene manufacturing cheaper, greener

Chemical Value Chain

Chemical engineering researchers have developed a new catalyst that significantly increases yield in styrene manufacturing, while simultaneously reducing energy use and greenhouse gas emissions.

March 6, 2021

Haldor Topsoe to build large-scale SOEC electrolyzer manufacturing facility

Chemical Value Chain

With efficiencies above 90%, Topsoe’s proprietary SOEC electrolyzers offer superior performance in electrolysis of water into hydrogen, when compared to today’s standard alkaline or PEM electrolyzers.

March 6, 2021

Chevron Phillips names new CEO 

Chemical Value Chain

Chevron Phillips Chemical announced that Bruce Chinn, currently president, Chevron Chemicals, will become chief executive officer. B.J. Hebert, currently executive vice president and chief operating officer, will become president and chief operating officer.

Send this to a friend